Synthetic Resveratrol Derivatives and Their Biological Activities: A Review

DOI: 10.4236/ojmc.2015.54006   PDF   HTML   XML   4,103 Downloads   4,877 Views   Citations


Resveratrol, a naturally derived stilbene that exists in various foods and beverages, has attracted extensive exploration due to its multiple biological activities, such as anticancer, antioxidant, cardiovascular protection, anti-inflammatory, antiviral, chemopreventive effect, neuroprotective effect, immunomodulation and so on. However, owing to its poor oral bioavailability, the application of resveratrol is greatly restricted. Because of that, a large amount of efforts had been made by researchers on designing its derivatives to obtain compounds with improved efficiency and low toxicity for developing more active drugs for clinical application. In this report, we review the current development of studying on resveratrol derivatives including their properties and activities. Additionally, this article also presents the synthetic routes of correlative resveratrol derivatives.

Share and Cite:

Liu, Y. , Liu, Y. , Chen, H. , Yao, X. , Xiao, Y. , Zeng, X. , Zheng, Q. , Wei, Y. , Song, C. , Zhang, Y. , Zhu, P. , Wang, J. and Zheng, X. (2015) Synthetic Resveratrol Derivatives and Their Biological Activities: A Review. Open Journal of Medicinal Chemistry, 5, 97-105. doi: 10.4236/ojmc.2015.54006.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Aggarwal, B.B., Bhardwaj, A., Aggarwal, R.S., Seeram, N.P., Shishodia, S. and Takada, Y. (2004) Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies. Anticancer Research, 24, 2783-2840.
[2] Yan, Y., Gao, Y.Y., Liu, B.Q., Niu, X.F., Zhuang, Y. and Wang, H.Q. (2010) Resveratrol-Induced Cytotoxicity in Human Burkitt’s Lymphoma Cells Is Coupled to the Unfolded Protein Response. BMC Cancer, 10, 445.
[3] Catalgol, B., Batirel, S., Taga, Y. and Ozer, N.K. (2012) Resveratrol: French Paradox Revisited. Frontiers in Pharmacology, 3, 141-158.
[4] Kelkel, M., Jacob, C., Dicato, M. and Diederich, M. (2010) Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies. Molecules, 15, 7035-7074.
[5] Takaoka, M.J. (1940) Of the Phenolic Substances of White Hellebore (Veratrum grandiflorum Loe. fil.). J Faculty Sci Hokkaido Imperial University, 3, 1-16.
[6] Chen, Y.M., Hu, F., Gao, Y.H., Ji, N., Liu, W.Z. and Hua, E.B. (2014) Design and Synthesis of Resveratrol Analogs. Springer-Verlag, Berlin Heidelberg.
[7] Mulakayala, C., Babajan, B., Madhusudana, P., Anuradha, C.M., Rao, R.M., Nune, R.P., Manna, S.K., Mulakayala, N. and Kumar, C.S. (2013) Synthesis and Evaluation of Resveratrol Derivatives as New Chemical Entities for Cancer. Journal of Molecular Graphics and Modelling, 41, 43-54.
[8] Simon, C., Britton, R.G., Cai, H., Gescher, A.J., Brown, K. and Jenkins, P.R. (2013) Novel Analogues of Resveratrol: Metabolism and Inhibition of Colon Cancer Cell Proliferation. Tetrahedron, 69, 6203-6212.
[9] He, S. and Yan, X.J. (2013) From Resveratrol to Its Derivatives: New Sources of Natural Antioxidant. Current Medicinal Chemistry, 20, 1005-1017.
[10] Frombauma, M., Clanche, S.L., Bonnefont-Rousselot, D. and Borderie, D. (2012) Antioxidant Effects of Resveratrol and Other Stilbene Derivatives on Oxidative Stress and NO Bioavailability: Potential Benefits to Cardiovascular Diseases. Biochimie, 94, 269-276.
[11] Vilar, S., Quezada, E., Santana, L., Uriarte, E., Yánez, M., Fraiz, N., Alcaide, C., Cano, E. and Orallo, F. (2006) Design, Synthesis, and Vasorelaxant and Platelet Antiaggregatory Activities of Coumarin-Resveratrol Hybrids. Bioorganic & Medicinal Chemistry Letters, 16, 257-261.
[12] Bertini, S., Calderone, V., Carboni, I., Maffei, R., Martelli, A., Martinelli, A., Minutolo, F., Rajabi, M., Testai, L., Tuccinardi, T., Ghidoni, R. and Macchia, M. (2010) Synthesis of Heterocycle-Based Analogs of Resveratrol and Their Antitumor and Vasorelaxing Properties. Bioorganic & Medicinal Chemistry, 18, 6715-6724.
[13] Chen, G.L., Shan, W., Wu, Y.L., Ren, L.X., Dong, J.H. and Ji, Z.Z. (2005) Synthesis and Anti-Infammatory Activity of Resveratrol Analogs. Chemical and Pharmaceutical Bulletin, 53, 1587-1590.
[14] Li, C., Fang, J.S., Lian, W.W., Pang, X.C., Liu, A.L. and Du, G.H. (2014) In Vitro Antiviral Effects and 3D QSAR Study of Resveratrol Derivatives as Potent Inhibitors of Influenza H1N1 Neuraminidase. Chemical Biology & Drug Design, 85, 427-438.
[15] Galindo, I., Hernáez, B., Berná, J., Fenoll, J., Cenis, J.L., Escribano, J.M. and Alonso, C. (2011) Comparative Inhibitory Activity of the Stilbenes Resveratrol and Oxyresveratrol on African Swine Fever Virus Replication. Antiviral Research, 91, 57-63.
[16] Chalal, M., Klinguer, A., Echairi, A., Meunier, P., Vervandier-Fasseur, D. and Adrian, M. (2014) Antimicrobial Activity of Resveratrol Analogues. Molecules, 19, 7679-7688.
[17] Ogas, T., Kondratyuk, T.P. and Pezzuto, J.M. (2013) Resveratrol Analogs: Promising Chemopreventive Agents. Annals of the New York Academy of Sciences, 1290, 21-29.
[18] Szekeres, T., Saiko, P., Fritzer-Szekeres, M., Djavan, B. and Jäger, W. (2011) Chemopreventive Effects of Resveratrol and Resveratrol Derivatives. Annals of the New York Academy of Sciences, 1215, 89-95.
[19] Richard, T., Pawlus, A.D., Iglésias, M.L., Pedrot, E., Waffo-Teguo, P., Mérillon, J.M. and Monti, J.P. (2011) Neuroprotective Properties of Resveratrol and Derivatives. Annals of the New York Academy of Sciences, 1215, 103-108.
[20] Li, F., Gong, Q., Dong, H. and Shi, J. (2012) Resveratrol, a Neuroprotective Supplement for Alzheimer’s Disease. Current Pharmaceutical Design, 18, 27-33.
[21] Fuggetta, M. and Mattivi, F. (2011) The Immunomodulating Activities of Resveratrol Glucosides in Humans. Recent Patents on Food, Nutrition & Agriculture, 3, 81-90.
[22] Lancon, A., Delmas, D., Osman, H., Thenot, J.P., Jannin, B. and Latruffe, N. (2004) Human Hepatic Cell Uptakeof Resveratrol: Involvement of both Passive Diffusion and Carrier-Mediated Process. Biochemical and Biophysical Research Communications, 316, 1132-1137.
[23] Walle, T., Hsieh, F., de Legge, M.H., Oatis Jr., J.E and Walle, U.K. (2004) High Absorption but Very Low Bioavailability of Oral Resveratrol in Humans. Drug Metabolism and Disposition, 32, 1377-1382.
[24] Hoshino, J., Park, E.J., Kondratyuk, T.P., Marler, L., Pezzuto, J.M., van Breemen, R.B., Mo, S., Li, Y. and Cushman, M. (2010) Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites. Journal of Medicinal Chemistry, 53, 5033-5043.
[25] Manna, S.K., Mukhopadhyay, A. and Aggarwal, B.B. (2000) Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1 and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation. The Journal of Immunology, 164, 6509-6519.
[26] Tsai, S.H., Lin-Shiau, S.Y. and Lin, J.K. (1999) Suppression of Nitric Oxide Synthase and the Down-Regulation of the Activation of NF-κB in Macrophages by Resveratrol. British Journal of Pharmacology, 126, 673-680.
[27] Fresco, P., Borges, F., Diniz, C. and Marques, M.P. (2006) New Insights on the Anticancer Properties of Dietary Polyphenols. Medicinal Research Reviews, 26, 747-766.
[28] Minutolo, F., Sala, G., Bagnacani, A., Bertini, S., Carboni, I., Placanica, G., Prota, G., Rapposelli, S., Sacchi, N., Macchia, M. and Ghidoni, R. (2005) Synthesis of a Resveratrol Analogue with High Ceramide-Mediated Proapoptotic Activity on Human Breast Cancer Cells. Journal of Medicinal Chemistry, 48, 6783-6786.
[29] Ruan, B.F., Huang, X.F., Ding, H., Xu, C., Ge, H.M., Zhu, H.L. and Tan, R.X. (2006) Synthesis and Cytotoxic Evaluation of a Series of Resveratrol Derivatives. Chemistry & Biodiversity, 3, 975-981.
[30] Liu, H.C., Dong, A.J., Gao, C.M., Tan, C.Y., Liu, H.X., Zu, X.Y. and Jiang, Y.Y. (2008) The Design, Synthesis, and Anti-Tumor Mechanism Study of N-Phosphoryl Amino Acid Modified Resveratrol Analogues. Bioorganic & Medicinal Chemistry, 16, 10013-10021.
[31] Liu, Q., Jin, W.W., Zhu, Y., Zhou, J.Y., Lu, M. and Zhang, Q. (2012) Synthesis of 3’-Methoxy-E-Diethylstilbestrol and Its Analogs as Tumor Angiogenesis Inhibitors. Steroids, 77, 419-423.
[32] Szaefer, H., Cichocki, M., Krajka-Kuzniak, V., Stefański, T., Sobiak, S., Licznerska, B. and Baer-Dubowska, W. (2014) The Effect of Resveratrol and Its Methylthio-Derivatives on NF-κB and AP-1 Signaling Pathways in HaCaT Keratinocytes. Pharmacological Reports, 66, 732-740.
[33] Fauconneau, B., Waffo-Teguo, P., Huguet, F., Barrier, L., Decendit, A. and Merillon, J.M. (1997) Comparative Study of Radical Scavenger and Antioxidant Properties of Phenolic Compounds from Vitis Vinifera Cell Cultures Using in vitro Tests. Life Sciences, 61, 2103-2110.
[34] Cai, Y.J., Fang, J.G., Ma, L.P., Yang, L. and Liu, Z.L. (2003) Inhibition of Free Radical-Induced Peroxidation of Rat Liver Microsomes by Resveratrol and Its Analogues. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1637, 31-38.
[35] Queiroz, A.N., Gomes, B.A., Moraes, W.M. and Borges, R.S. (2009) A Theoretical Antioxidant Pharmacophore for Resveratrol. European Journal of Medicinal Chemistry, 44, 1644-1649.
[36] Caruso, F., Tanski, J., Villegas-Estrada, A. and Rossi, M. (2004) Structural Basis for Antioxidant Activity of Trans- Resveratrol: Ab Initio Calculations and Crystal and Molecular Structure. Journal of Agricultural and Food Chemistry, 52, 7279-7285.
[37] Orallo, F. (2006) Comparative Studies of the Antioxidant Effects of Cis- and Trans-Resveratrol. Current Medicinal Chemistry, 13, 87-98.
[38] Stivala, L.A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., Forti, L., Pagnoni, U.M., Albini, A., Prosperi, E. and Vannini, V. (2001) Specific Structural Determinants Are Responsible for the Antioxidant Activity and the Cell Cycle Effects of Resveratrol. The Journal of Biological Chemistry, 276, 22586-22594.
[39] Antus, C., Radnai, B., Dombovari, P., Fonai, F., Avar, P., Matyus, P., Racz, B., Sumegi, B. and Veres, B. (2014) Anti-Inflammatory Effects of a Triple-Bond Resveratrol Analog: Structure and Function Relationship. European Journal of Pharmacology, 748, 61-67.
[40] Lu, C.J., Guo, Y.Y., Yan, J., Luo, Z.H., Luo, H.B., Yan, M., Huang, L. and Li, X.S. (2013) Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease. Journal of Medicinal Chemistry, 56, 5843-5859.

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.